ArticleOphthalmology science

Association of Dipeptidyl Peptidase-4 Inhibitors with Glaucoma Risk in Patients with Type 2 Diabetes: A Nationwide Cohort Study.

Yi-An Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.